COX4I2 and central nervous system cancer: Although the changes in metabolites detected in our analyses may also be products or substrates in cellular pathways other than those we discussed, the metabolic profiles described agree with those in our recent publications, in which we characterized the bioenergetic profile of COX4-1- and COX4-2-expressing glioma cells [2,3,4,5].